Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | octaprenyl pyrophosphate synthase, putative | 0.0248 | 0.1809 | 0.1577 |
Plasmodium falciparum | V-type K+-independent H+-translocating inorganic pyrophosphatase | 0.1096 | 1 | 1 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 0.8032 |
Schistosoma mansoni | glutathione synthetase | 0.0248 | 0.1809 | 0.1964 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0898 | 0.8087 | 0.5 |
Trypanosoma cruzi | vacuolar-type proton translocating pyrophosphatase 1 | 0.1096 | 1 | 1 |
Onchocerca volvulus | 0.009 | 0.0275 | 0.5 | |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0338 | 0.2675 | 0.3072 |
Loa Loa (eye worm) | hexokinase | 0.009 | 0.0275 | 0.0341 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 0.8032 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0898 | 0.8087 | 1 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0248 | 0.1809 | 0.1964 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0248 | 0.1809 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 0.8032 |
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0338 | 0.2675 | 0.3308 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0898 | 0.8087 | 1 |
Leishmania major | polyprenyl synthase, putative | 0.0338 | 0.2675 | 0.2468 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0248 | 0.1809 | 0.2237 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0898 | 0.8087 | 0.5 |
Onchocerca volvulus | 0.009 | 0.0275 | 0.5 | |
Trypanosoma cruzi | solanesyl-diphosphate synthase, putative | 0.0248 | 0.1809 | 0.1577 |
Echinococcus multilocularis | prenyl (decaprenyl) diphosphate synthase | 0.0248 | 0.1809 | 0.1964 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 1 |
Plasmodium falciparum | V-type H(+)-translocating pyrophosphatase, putative | 0.1096 | 1 | 1 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0898 | 0.8087 | 1 |
Plasmodium falciparum | octaprenyl pyrophosphate synthase | 0.0248 | 0.1809 | 0.1577 |
Trypanosoma cruzi | solanesyl-diphosphate synthase, putative | 0.0248 | 0.1809 | 0.1577 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.0248 | 0.1809 | 1 |
Plasmodium vivax | vacuolar-type H+ pumping pyrophosphatase, putative | 0.1096 | 1 | 1 |
Trypanosoma brucei | Pyrophosphate-energized vacuolar membrane proton pump 1 | 0.1096 | 1 | 1 |
Echinococcus granulosus | prenyl decaprenyl diphosphate synthase | 0.0248 | 0.1809 | 0.1964 |
Trypanosoma cruzi | Vacuolar proton pyrophosphatase 1, putative | 0.1096 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0248 | 0.1809 | 0.5 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0338 | 0.2675 | 0.2468 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0248 | 0.1809 | 0.1577 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0898 | 0.8087 | 1 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0338 | 0.2675 | 0.3072 |
Onchocerca volvulus | 0.009 | 0.0275 | 0.5 | |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0898 | 0.8087 | 0.8032 |
Trypanosoma brucei | Pyrophosphate-energized vacuolar membrane proton pump 2, putative | 0.1096 | 1 | 1 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0248 | 0.1809 | 0.5 |
Trypanosoma cruzi | solanesyl-diphosphate synthase | 0.0248 | 0.1809 | 0.1577 |
Loa Loa (eye worm) | hexokinase | 0.009 | 0.0275 | 0.0341 |
Echinococcus granulosus | decaprenyl diphosphate synthase subunit 1 | 0.0248 | 0.1809 | 0.1964 |
Leishmania major | solanesyl-diphosphate synthase, putative | 0.0248 | 0.1809 | 0.1577 |
Schistosoma mansoni | trans-prenyltransferase | 0.0248 | 0.1809 | 0.1964 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0898 | 0.8087 | 1 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0898 | 0.8087 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.009 | 0.0275 | 0.0341 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.0248 | 0.1809 | 1 |
Trypanosoma brucei | solanesyl-diphosphate synthase, putative | 0.0248 | 0.1809 | 0.1577 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0898 | 0.8087 | 0.8032 |
Brugia malayi | geranylgeranyl pyrophosphate synthetase | 0.0338 | 0.2675 | 0.3072 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0338 | 0.2675 | 0.2468 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0898 | 0.8087 | 0.8032 |
Echinococcus multilocularis | decaprenyl diphosphate synthase subunit 1 | 0.0248 | 0.1809 | 0.1964 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0248 | 0.1809 | 0.5 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0898 | 0.8087 | 0.8032 |
Plasmodium vivax | V-type H(+)-translocating pyrophosphatase, putative | 0.1096 | 1 | 1 |
Toxoplasma gondii | V-type H(+)-translocating pyrophosphatase VP1 | 0.1096 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0898 | 0.8087 | 0.5 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.0248 | 0.1809 | 1 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0898 | 0.8087 | 1 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0338 | 0.2675 | 0.3072 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0338 | 0.2675 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3000 nM | In vitro inhibition of electric eel acetylcholinesterase | ChEMBL. | 11495583 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.